Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Free cash flow yield
Latest
-81.23%
↑ 53% vs avg
Percentile
P25
Within normal range
Streak
1 yr
Consecutive growthElevated
Average
-173.19%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -81.23% | +93.3% |
| 2023 | -1220.19% | -2055.2% |
| 2022 | -56.61% | -41.3% |
| 2021 | -40.07% | -91.4% |
| 2020 | -20.93% | -232.5% |
| 2019 | -6.30% | -91.5% |
| 2018 | -3.29% | -115.5% |
| 2017 | 21.21% | +111.3% |
| 2016 | -187.99% | -37.7% |
| 2015 | -136.56% | - |